PTIX (Protagenic) Net earnings per share change in current year
Protagenic Therapeutics (PTIX) demonstrates stability in its relative annual growth of net income per share, driven by streamlined air delivery of research components. Business revenues rely on the future release of treatments for anxiety disorders, although dependence on investments and the risk of test failure pose threats. Meanwhile, the level of 0.00 represents the current value of this indicator, capturing the adaptability of the PTIX model to market changes.
Financial and market metric breakdowns for protagenic.com (PTIX)
- market value and analyst target forecast:
- business market valuation indicators:
- book value of equity indicators:
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Protagenic Therapeutics|PTIX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Protagenic Therapeutics, Inc.|PTIX - Company Total Debt|Debt to Net Assets Ratio Protagenic Therapeutics, Inc.|PTIX - Company Long-Term Liabilities|Amount of Current Liabilities Protagenic Therapeutics|Intermediate Coverage Ratio protagenic.com
- company profitability and valuation multiples indicators:
PTIX - Net Profit|Expected Net Profit Protagenic Therapeutics|PTIX - Price to Earnings Ratio|Future Price to Earnings Multiple Protagenic Therapeutics, Inc.|PTIX - PEG Multiple|EV/EBITDA Multiple Protagenic Therapeutics, Inc.|PTIX - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Protagenic Therapeutics|PTIX - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months protagenic.com|PTIX - Net earnings per share growth this year|Earnings growth forecast for next year Protagenic Therapeutics
- revenue and sales proceeds data:
Summary company analysis:Protagenic (PTIX)
Protagenic Therapeutics (PTIX) maintains a costly cold chain for the transportation of biologics, which directly impacts operating expenses. The earnings per share (EPS) trend measures the percentage deviation of current financial results from the previous year's figures, reflecting the efficiency of cost management. Analyzing the annual EPS change allows investors to assess the business's resilience to logistics costs and the real rate of capital growth.
Key competitors
Biogen Inc (BIIB) - Earnings growth in current year|NBIX (Neurocrine Biosciences Inc) - Earnings growth in current year|RGC - Net earnings per share change in current year|Earnings growth in current year AXSM|ACAD - Earnings per share growth rate in current year|Earnings per share growth in current year Xenon XENE|VKTX: Earnings per share growth this year|Supernus Pharma - Earnings growth in current year|Expected net earnings per share growth this year Catalyst Corp CPRX|DNLI: Earnings growth in current year|Net earnings per share growth this year harmonybiosciences.com|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Net earnings per share growth this year TRVI (Trevi Pharma)|Net earnings per one share growth for the current year PRAX|Earnings growth in current year AVXL (Anavex Life Sciences)|Earnings per share increase in current year CBLL|Prothena - Earnings growth in current year|Earnings per share growth rate in current year Alector, Inc.|Annexon Inc. (ANNX) - Earnings per share growth in current year|Omeros - Earnings per share increase in current year|NGNE (Neurogene Inc.) - Earnings growth in current year|Earnings growth in current year acimmune.com|Earnings per share growth in current year Voyager Therapeutics, Inc. (VYGR)|NMRA: Earnings per share trend in current year|Earnings growth in current year SCLX (Scilex Holding Co.)|Tevogen Bio Inc. (TVGN) - Earnings per share growth rate in current year|ACOG: Net earnings per share growth this year|CGTX - Earnings growth in current year|IKT (Inhibikase Therapeutics, Inc.) - Net earnings per share growth this year|SAVA: Net earnings per one share growth for the current year|ASRT (Assertio Holdings) - Earnings growth in current year|Coya (COYA) - Expected net earnings per share growth this year|Earnings growth in current year VTGN|Net earnings per share growth this year ovidrx.com OVID|Earnings per share growth in current year Acumen Pharmaceuticals, Inc. ABOS|Expected net earnings per share growth this year CervoMed, Inc. (CRVO)|ATHE - Earnings per share growth in current year|Earnings per share trend in current year CLNN|PEPG (pepgen.com) - Net earnings per share growth this year|JUNS: Net earnings per one share growth for the current year|RLMD (Relmada Therapeutics, Inc.) - Earnings growth in current year|Annovis Bio Inc (ANVS) - Expected net earnings per share growth this year|Net earnings per share growth this year GRCE (Grace Therapeutics, Inc.)|Firefly Neuro - Earnings per share growth this year|Earnings per share growth in current year Klotho Neurosciences KLTO|NRSN: Earnings per share growth this year|Reviva Pharmaceuticals Holdings, Inc. - Earnings growth in current year|Earnings per share growth rate in current year MetaVia Inc|NRXS (NeurAxis, Inc) - Net earnings per share growth this year|Helius Medical Technologies (HSDT) - Earnings growth in current year|Earnings per share growth in current year Passage Bio Inc.|NEUP: Earnings per share increase in current year|Earnings per share growth in current year Minerva Neurosciences, Inc. (NERV)|ATHA - Earnings per share growth rate in current year|Earnings per share growth in current year Addex Therapeutics, Ltd. ADXN|ALZN (Alzamend Neuro Inc.) - Earnings per share trend in current year|CYCN - Earnings per share growth in current year|Earnings per share increase in current year KTTA (Pasithea Therapeutics)|cortigent.com (CRGT) - Earnings per share growth in current year|Earnings per share growth rate in current year Avenue Therapeutics Inc. (ATXI)|Net earnings per share growth this year BCLI|CARA (Cara Therapeutics Inc) - Net earnings per one share growth for the current year|Earnings growth in current year CHRO|Earnings growth in current year eliemtx.com (ELYM)|Earnings growth in current year ITCI (Intra-Cellular Therapies, Inc.)|Net earnings per share change in current year Longboard Pharmaceuticals Inc|Marinus - Earnings growth in current year|Earnings per share growth rate in current year NKGen Biotech Corp|NeuroBo Pharmaceuticals (NRBO) - Earnings per share growth in current year|Earnings per share growth this year SAGE|SNPX (Synaptogenix) - Earnings growth in current year|Trevena Inc. (TRVN) - Expected net earnings per share growth this year|Earnings growth in current year VIGL|Net earnings per share growth this year anewmeds.com WENA|Cerevel Therapeutics - Net earnings per share growth this year
